Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSM in the Treatment of Low Back Pain
NCT02268305Phase 3Completed
- Sponsor
- Mike O'Callaghan Federal Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylsulfonylmethane in low back pain (LBP), sponsored by Mike O'Callaghan Federal Medical Center. Started Feb 2015; status: completed.
02
Drugs
methylsulfonylmethane
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT02268305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268305.